11-Feb-2016 - Lonza will make a candidate heart failure gene therapy for Renova Therapeutics under the second biomanufacturing deal it has signed this week.
10-Feb-2016 - GSK will test a stability enhancement technology developed by VBI Vaccines in a deal announced this week.
08-Feb-2016 - Up to 90% of new chemical entities having properties that make them a challenge to successfully formulate, says Juniper Pharmaceuticals which has won a reformulation and manufacturing contract from PharmAust.
04-Feb-2016 - Novartis subsidiary Sandoz will commercialise small and large molecule injectables using French delivery tech firm MedinCell’s subcutaneous controlled release platform.
04-Feb-2016 - MannKind has spoken about Receptor Life Science, a newly-formed company which last month licensed the Technosphere inhaled delivery platform from the struggling firm.
29-Jan-2016 - Novozymes’ albumin technologies division Albumedix has bought Eleven Biotherapeutics’ half-life extension assets.
27-Jan-2016 - Drug-loaded dental implants which release payload on-demand could alleviate invasive procedures associated with chronic diseases, scientists suggest.
27-Jan-2016 - Recipharm has raised SEK276m ($32m) to part finance the acquisition of a majority stake in Indian CMO Nitin Life Sciences that it announced in October.
27-Jan-2016 - Austrianova has launched cell banking and fill finish services for cell therapy developers at its facility in Singapore.
26-Jan-2016 - An associate professor at MIT is re-engineering the malaria parasite to act as vehicle for drug delivery.
25-Jan-2016 - A Zika vaccine is a long way off according to a UK academic who suggested vaccines for related viruses could be used as delivery vectors to accelerate development.
25-Jan-2016 - Catalent will pursue strategic acquisitions and licensing in 2016, said VP Marketing & Strategy Elliott Berger, noting growth areas include complex delivery technologies and specialised logistics.
21-Jan-2016 - Mucosis has been awarded a Wellcome Trust grant of €3.7m ($4m) to help develop a Respiratory Syncytial Virus (RSV) vaccine using its intranasal delivery platform.
21-Jan-2016 - Johnson Matthey has expanded its UK biocatalysis R&D operations in response to growing drug industry demand.
20-Jan-2016 - Novozymes’ new subsidiary Albumedix has announced its intention to develop biobetters and says the first candidate could be in Phase I trials by 2019.
18-Jan-2016 - UK-based biotech Centauri Therapeutics has acquired a “programmable immunity” aptamer technology from Altermune Technologies.
18-Jan-2016 - Researchers have found a way to illuminate and track a common cancer drug, a method which shows promise in advancing personalized medicine.
14-Jan-2016 - A new liquid-metal drug delivery method shows promise in enhancing the effectiveness of drugs.
14-Jan-2016 - MannKind says its Technosphere delivery platform could yield short-term cash and drive long-term growth.
12-Jan-2016 - Insulet CEO Duane DeSisto will no longer be taking the top job at MannKind Corporation after the inhaled insulin developer withdrew the offer.
11-Jan-2016 - Allergan has acquired neurotoxin company Anterios for $90m (€83m).
11-Jan-2016 - Fresenius Kabi has moved into the prefilled syringe space by acquiring Becton, Dickinson and Company’s injectables business and US manufacturing plant.
07-Jan-2016 - After securing partnerships with AbbVie and Sanofi, Unilife has announced another exclusive agreement for a wearable injector device with Amgen.
07-Jan-2016 - Despite Sanofi’s “conflicted” management and subsequent abandonment of Afrezza, the market opportunity for inhaled insulin is still huge, according to Dance Biopharm's CEO.
06-Jan-2016 - Sanofi has abandoned Afrezza less than a year after its launch, but the future of the inhaled insulin product is secure according to developer MannKind.